Takeda will be investing approximately $30 billion into its U.S. operations over the next five years, the company announced.

Provides ReciBioPharm’s customers with access to NewBiologix’s Xcell-Eng-HEK293 celllines to develop and manufacture AAV ...

Gilead Sciences is investing an additional $11 billion into its U.S. operations, the company announced this week, bringing ...

ACG Packaging Materials’ greenhouse gas emission reduction targets have been validated by the Science Based Targets ...

How Praxis Packaging delivers flexible, reliable solutions for pharmaceutical contract packaging needs. As pressures on ...

Schreiner MediPharm’s new Digital Display Label allows trial sponsors to eliminate time-consuming manual relabeling.

Bain Capital’s Real Estate team and Botanic Properties, a real estate investment and development firm, have acquired 45 ...

To enhance manufacturing capacity as part of an effort to control complex supply chains and align with U.S. R&D activities.

TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in SCHOTT ...

ProBioGen has partnered with Polpharma Biologics to conduct high-performance cell line development services for a biosimilar ...

Unlock the full potential of poorly soluble compounds with Spray Dried Dispersions (SDDs). This webinar will explore key ...

GeneFab, a cell and gene therapy-focused CRDMO, has partnered with RegCell, a biotech company advancing regulatory T cell ...